论文部分内容阅读
据悉,目前从事艾滋病研究的科学家们正在研制一些能在HIV试图与细胞结合并感染细胞的途中阻止HIV感染的药物。该类药物的T-20现已进入临床试验。但由于T-20
It is reported that scientists who are currently engaged in AIDS research are developing some of the drugs that can prevent HIV infection on the way HIV tries to bind cells and infect cells. T-20 of these drugs has now entered clinical trials. But thanks to T-20